1-2 of 2
Laurence lacotte-Thierry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 Study of Orociep All Oral Regimen with Idarubicin, Cyclophosphamide, Etoposide, Prednisolone in Combination to Intravenous Rituximab in Elderly Patients with Disseminated High Grade Non Hodgkin Lymphoma. Final Analysis

Stephanie Guidez, Laurence lacotte-Thierry, Cecile Tomowiak, MD, Antoine Machet, Carine Motard, Anthony Levy, Cécile Gruchet, Florence Sabirou, Arthur Bobin, Niels Moya, Thomas Systchenko, Jocelyn Barrier, MD, Carine le Du, Emmanuel Fleck, MD, Diane Chuillet-Moreau, Michele Chabin, Xavier Leleu, MD PhD, Joelle Guilhot, PhD, Vincent Delwail, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5207.
https://doi.org/10.1182/blood.V130.Suppl_1.5207.5207
Published: 2017
Journal Articles

Phase I/II Study of Escalating Doses of Idarubicin Orally Given with Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patients with Disseminated High Grade Non Hodgkin Lymphoma.

Amélie Fauveau, PharmD, Laurence Lacotte-Thierry, MD, Emmanuel Fleck, MD, Jean Yves Colin, MD, François Guilhot, MD, Michèle Chabin, PharmD, Alice Langlois, CRA, Joëlle Guilhot, MSci, Vincent Delwail, MD
Journal: Blood
Blood (2009) 114 (22): 3695.
https://doi.org/10.1182/blood.V114.22.3695.3695
Published: 2009